Glucophage Alternatives Compared
| Glucophage | Rybelsus | Mounjaro |
|
|---|
| Glucophage (metformin) | Rybelsus (semaglutide) | Mounjaro (tirzepatide) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Diabetes - Type 2. Glucophage may also be used for purposes not listed in this medication guide. |
Prescription only
Rybelsus (semaglutide) is an oral medicine that can be used as a first-line medication to improve blood sugar control in adults over the age of 18 with type 2 diabetes. It works by mimicking the... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Diabetes - Type 2. Mounjaro may also be used for purposes not listed in this medication guide. |
Related suggestions Diabetes, Type 2
Popular comparisons
|
|||||||||||||||
| More about Glucophage (metformin) | More about Rybelsus (semaglutide) | More about Mounjaro (tirzepatide) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Glucophage has an average rating of 7.0 out of 10 from a total of 39 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 22% reported a negative effect. |
Rybelsus has an average rating of 6.3 out of 10 from a total of 251 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 26% reported a negative effect. |
Mounjaro has an average rating of 8.6 out of 10 from a total of 1000 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 7% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: Glucophage side effects in more detail. |
See also: Rybelsus side effects in more detail. |
See also: Mounjaro side effects in more detail. |
||||||||||||||||
| Generic Availability | ||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Rybelsus prices |
View all Mounjaro prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other metformin brands include: Glumetza | Other semaglutide brands include: Ozempic, Wegovy | Other tirzepatide brands include: Zepbound | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
4.5 hours |
168 hours |
120 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 367 drugs are known to interact with Glucophage:
|
A total of 264 drugs are known to interact with Rybelsus:
|
A total of 410 drugs are known to interact with Mounjaro:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
||||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
March 03, 1995 |
N/A |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.